H Lundbeck A/S logo

LUN - H Lundbeck A/S Share Price

DKK195 -1.0  -0.5%

Last Trade - 16/04/21

Large Cap
Market Cap £4.51bn
Enterprise Value £4.98bn
Revenue £2.06bn
Position in Universe 137th / 1831
Unlock LUN Revenue
Relative Strength (%)
1m -17.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -28.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
14,594 15,634 17,234 18,117 17,036 17,672 16,923 17,814 +3.9%
+116.5 +51.0 -32.2 +2.5 -28.1 +36.7
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, H.Lundbeck A/S revenues increased 4% to DKR17.67B. Net incomedecreased 32% to DKR1.58B. Revenues reflect North Americasegment increase of 2% to DKR9.79B, International Marketssegment increase of 4% to DKR4.06B. Net income was offsetby Research and development costs - Balanci increase of 25%to DKR2.65B (expense), Sales and distribution costs-Balancing increase of 7% to DKR3.36B (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for LUN
Graphical History


LUN Revenue Unlock LUN Revenue

Net Income

LUN Net Income Unlock LUN Revenue

Normalised EPS

LUN Normalised EPS Unlock LUN Revenue

PE Ratio Range

LUN PE Ratio Range Unlock LUN Revenue

Dividend Yield Range

LUN Dividend Yield Range Unlock LUN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
LUN EPS Forecasts Unlock LUN Revenue
Profile Summary

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated October 14, 1950
Public Since January 1, 1999
No. of Shareholders: n/a
No. of Employees: 5,628
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Euromid ,
Exchange OMX Nordic Exchange - Copenhagen
Shares in Issue 198,698,326
Free Float (0.0%)
Eligible for
LUN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for LUN
Upcoming Events for LUN
Tuesday 11th May, 2021
Q1 2021 H Lundbeck A/S Earnings Release
Wednesday 18th August, 2021
Q2 2021 H Lundbeck A/S Earnings Release
Frequently Asked Questions for H Lundbeck A/S
What is the H Lundbeck A/S share price?

As of 16/04/21, shares in H Lundbeck A/S are trading at DKK195, giving the company a market capitalisation of £4.51bn. This share price information is delayed by 15 minutes.

How has the H Lundbeck A/S share price performed this year?

Shares in H Lundbeck A/S are currently trading at DKK195 and the price has moved by -11.48% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the H Lundbeck A/S price has moved by -31.41% over the past year.

What are the analyst and broker recommendations for H Lundbeck A/S?

Of the analysts with advisory recommendations for H Lundbeck A/S, there are there are currently 3 "buy" , 7 "hold" and 0 "sell" recommendations. The overall consensus recommendation for H Lundbeck A/S is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will H Lundbeck A/S next release its financial results?

H Lundbeck A/S is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the H Lundbeck A/S dividend yield?

The H Lundbeck A/S dividend yield is 1.28% based on the trailing twelve month period.

Does H Lundbeck A/S pay a dividend?

Last year, H Lundbeck A/S paid a total dividend of 2.5, and it currently has a trailing dividend yield of 1.28%. Looking ahead, H Lundbeck A/S has not announced an ex-dividend date yet.

When does H Lundbeck A/S next pay dividends?

H Lundbeck A/S has yet to annouce their ex-dividend date. The historic dividend yield on H Lundbeck A/S shares is currently 1.28%.

How do I buy H Lundbeck A/S shares?

To buy shares in H Lundbeck A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of H Lundbeck A/S?

Shares in H Lundbeck A/S are currently trading at DKK195, giving the company a market capitalisation of £4.51bn.

Where are H Lundbeck A/S shares listed? Where are H Lundbeck A/S shares listed?

Here are the trading details for H Lundbeck A/S:

Country of listing: Denmark
Exchange: CPH
Ticker Symbol: LUN
What kind of share is H Lundbeck A/S?

Based on an overall assessment of its quality, value and momentum, H Lundbeck A/S is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a H Lundbeck A/S share price forecast 2021?

Shares in H Lundbeck A/S are currently priced at DKK195. At that level they are trading at 29.67% discount to the analyst consensus target price of 0.00.

Analysts covering H Lundbeck A/S currently have a consensus Earnings Per Share (EPS) forecast of 10.04 for the next financial year.

How can I tell whether the H Lundbeck A/S share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like H Lundbeck A/S. Over the past six months, the relative strength of its shares against the market has been -15.94%. At the current price of DKK195, shares in H Lundbeck A/S are trading at -9.96% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the H Lundbeck A/S PE Ratio?

The H Lundbeck A/S PE ratio based on its reported earnings over the past 12 months is 13.97. The shares are currently trading at DKK195.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of H Lundbeck A/S?

H Lundbeck A/S's management team is headed by:

Lars Bang - EVP
Anders Goetzsche - CFO
Lars Rasmussen - CHM
Henrik Sindal Jensen - DRC
Lene Skole-Soerensen - VCH
Lars Holmqvist - DRC
Jacob Tolstrup - EVP
Peter Anastasiou - EVP
Henrik Andersen - IND
Ludovic Tranholm Otterbein - DRC
Rikke Kruse Andreasen - DRC
Deborah Dunsire - PRE
Johan Luthman - EVP
Keld Flintholm Joergensen - EVP
Elise Hauge - EVP
Who are the major shareholders of H Lundbeck A/S?

Here are the top five shareholders of H Lundbeck A/S based on the size of their shareholding:

Lundbeckfond Invest Investment Advisor
Percentage owned: 68.97% (137.4m shares)
Invesco Advisers, Inc. Investment Advisor
Percentage owned: 1.01% (2.00m shares)
Invesco Global Opportunities Fund Mutual Fund
Percentage owned: 1% (2.00m shares)
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund
Percentage owned: 0.86% (1.71m shares)
Statens Pensjonsfond Utland Mutual Fund
Percentage owned: 0.86% (1.71m shares)
Similar to LUN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.